HPR82 Assessment of Supporting Evidence and Postmarketing Requirements for Therapeutic Indications With Real-Time Oncology Drug Review, 2018-2023
| Autor: | Mooghali, M, Mohammad, A, Wallach, JD, Mitchell, AP, Ross, JS, Ramachandran, R |
|---|---|
| Zdroj: | In Value in Health June 2024 27(6) Supplement:S208-S208 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect